A role for α-synuclein in the regulation of dopamine biosynthesis

Journal of Neuroscience

Volumn 22, Issue 8, 2002, Pages 3090-3099

  Perez, Ruth G ^a   Waymire, Jack C ^b   Lin, Eva ^a   Liu, Jen J ^a   Guo, Fengli ^a   Zigmond, Michael J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

14 3 3; MN9D; Parkinson's disease; Phosphorylation; Rat brain; Tyrosine hydroxylase

Indexed keywords

ALPHA SYNUCLEIN; CHAPERONE; MUTANT PROTEIN; RECOMBINANT PROTEIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CELL LEVEL; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINE UPTAKE; DOPAMINERGIC NERVE CELL; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; IMMUNOELECTRON MICROSCOPY; IMMUNOPRECIPITATION; METABOLIC REGULATION; MOUSE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

EID: 0037092442     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-08-03090.2002     Document Type: Article

References (73)

1. Abeliovich A, Schmitz Y, Farinas I, Choi-Lundberg D, Ho WH, Castillo PE, Shinsky N, Verdugo JM, Armanini M, Ryan A, Hynes M, Phillips H, Sulzer D, Rosenthal A (2000) Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25:239-252.
2. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington: Clinical, morphological, and neurochemical correlations. J Neurol Sci 20:415-455.
3. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3:1301-1306.
4. Bevilaqua LR, Graham ME, Dunkley PR, von Nagy-Felsobuki EI, Dickson PW (2001) Phosphorylation of ser19 alters the conformation of tyrosine hydroxylase to increase the rate of phosphorylation of ser40. J Biol Chem 276:40411-40416.
5. Broadie K, Rushton E, Skoulakis EM, Davis RL (1997) Leonardo, a Drosophila 14-3-3 protein involved in learning, regulates presynaptic function. Neuron 19:391-402.
6. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857-868.
7. Choi HK, Won LA, Kontur PJ, Hammond DN, Fox AP, Wainer BH, Hoffmann PC, Heller A (1991) Immortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion. Brain Res 552:67-76.
8. Choi HK, Won L, Roback JD, Wainer BH, Heller A (1992) Specific modulation of dopamine expression in neuronal hybrid cells by primary cells from different brain regions. Proc Natl Acad Sci USA 89:8943-8947.
9. Conway KA, Harper JD, Lansbury PT (1998) Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat Med 4:1318-1320.
10. Conway KA, Lee SJ, Rochet JC, Ding TT, Harper JD, Williamson RE, Lansbury Jr PT (2000) Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants. Ann NY Acad Sci 920:42-45.
11. Conway KA, Rochet JC, Bieganski RM, Lansbury Jr PT (2001) Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alphasynuclein adduct. Science 294:1346-1349.
12. Davidson WS, Jonas A, Clayton DF, George JM (1998) Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem 273:9443-9449.
13. El-Agnaf OM, Irvine GB (2000) Review: Formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins. J Struct Biol 130:300-309.
14. Feany MB, Bender WW (2000) A Drosophila model of Parkinson's disease. Nature 404:394-398.
15. Galvin JE, Lee VM, Trojanowski JQ (2001) Synucleinopathies: Clinical and pathological implications. Arch Neurol 58:186-190.
16. Giasson BI, Uryu K, Trojanowski JQ, Lee VM (1999) Mutant and wildtype human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro. J Biol Chem 274:7619-7622.
17. Glass MJ, Huang J, Aicher SA, Milner TA, Pickel VM (2001) Subcellular localization of the α-2A-adrenergic receptors in the rat medial nucleus tractus solitarius: Regional targeting and relationship with catecholamine neurons. J Comp Neurol 433:193-207.
18. Golbe LI, Di Iorio G, Sanges G, Lazzarini AM, La Sala S, Bonavita V, Duvoisin RC (1996) Clinical genetic analysis of Parkinson's disease in the Contursi kindred. Ann Neurol 40:767-775.
19. Graham DG (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol Pharmacol 14:633-643.
20. Hashimoto M, Hsu LJ, Sisk A, Xia Y, Takeda A, Sundsmo M, Masliah E (1998) Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: Relevance for Lewy body disease. Brain Res 799:301-306.
21. Hastings TG, Lewis DA, Zigmond MJ (1996) Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc Natl Acad Sci USA 93:1956-1961.
22. Haycock JW (1990) Phosphorylation of tyrosine hydroxylase in situ at serine 8, 19, 31, and 40. J Biol Chem 265:11682-11691.
23. Hornykiewicz O, Kish SJ (1986) Biochemical pathophysiology of Parkinson's disease. In: Advances in Neurology, Vol 45, Parkinson's Disease (Yahr MD, Bergmann KJ, eds). pp 19-34. New York: Raven.
24. Ichimura T, Isobe T, Okuyama T, Takahashi N, Araki K, Kuwano R, Takahashi Y (1988) Molecular cloning of cDNA coding for brainspecific 14-3-3 protein, a protein kinase-dependent activator of tyrosine and tryptophan hydroxylases. Proc Natl Acad Sci USA 85:7084-7088.
25. Irizarry MC, Kim TW, McNamara M, Tanzi RE, George JM, Clayton DF, Hyman BT (1996) Characterization of the precursor protein of the non-A beta component of senile plaques (NACP) in the human central nervous system. J Neuropathol Exp Neurol 55:889-895.
26. Itagaki C, Isobe T, Taoka M, Natsume T, Nomura N, Horigome T, Omata S, Ichinose H, Nagatsu T, Greene LA, Ichimura T (1999) Stimulus-coupled interaction of tyrosine hydroxylase with 14-3-3 proteins. Biochemistry 38:15673-15680.
27. Jackson D, Abercrombie ED, Zigmond MJ (1993) Impact of L-dopa on striatal acetylcholine release: Effects of 6-hydroxydopamine. J Pharmacol Exp Ther 267:912-918.
28. Jenco JM, Rawlingson A, Daniels B, Morris AJ (1998) Regulation of phospholipase D2: Selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins. Biochemistry 37:4901-4909.
29. Jenner P, Olanow CW (1998) Understanding cell death in Parkinson's disease. Ann Neurol 44:S72-84.
30. Jensen PH, Nielsen MS, Jakes R, Dotti CG, Goedert M (1998) Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J Biol Chem 273:26292-26294.
31. Kim TD, Paik SR, Yang CH, Kim J (2000) Structural changes in alphasynuclein affect its chaperone-like activity in vitro. Protein Sci 9:2489-2496.
32. Kleppe R, Toska K, Haavik J (2001) Interaction of phosphorylated tyrosine hydroxylase with 14-3-3 proteins: Evidence for a phosphoserine 40-dependent association. J Neurochem 77:1097-1107.
33. Kowall NW, Hantraye P, Brouillet E, Beal MF, McKee AC, Ferrante RJ (2000) MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons. NeuroReport 11:211-213.
34. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O (1998) Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat Genet 18:106-108.
35. Kumer SC, Vrana KE (1996) Intricate regulation of tyrosine hydroxylase activity and gene expression. J Neurochem 67:443-462.
36. Lee FJ, Liu F, Pristupa ZB, Niznik HB (2001) Direct binding and functional coupling of α-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis. FASEB J 15:916-926.
37. Liu Y Peter D, Roghani A, Schuldiner S, Prive GG, Eisenberg D, Brecha N, Edwards RH (1992) A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter. Cell 70:539-551.
38. Lotharius J, O'Malley KL (2000) The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity. J Biol Chem 275:38581-38588.
39. Markopoulou K, Wszolek ZK, Pfeiffer RF, Chase BA (1999) Reduced expression of the G209A alpha-synuclein allele in familial Parkinsonism. Ann Neurol 46:374-381.
40. Maroteaux L, Campanelli JT, Scheller RH (1988) Synuclein: A neuronspecific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 8:2804-2815.
41. Masliah, E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: Implications for neurodegenerative disorders. Science 287:1265-1269.
42. Matsuoka Y, Vila M, Lincoln S, McCormack A, Picciano M, LaFrancois J, Yu X, Dickson D, Langston WJ, McGowan E, Farrer M, Hardy J, Duff K, Przedborski S, DiMonte DA (2001) Lack of nigral pathology in transgenic mice expressing human α-synuclein driven by the tyrosine hydroxylase promoter. Neurobiol Dis 8:535-539.
43. Murphy DD, Rueter SM, Trojanowski JQ, Lee VM (2000) Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J Neurosci 20:3214-3220.
44. Muslin AJ, Xing H (2000) 14-3-3 Proteins: Regulation of subcellular localization by molecular interference. Cell Signal 12:703-709.
45. Nagatsu T, Levitt T, Udenfriend S (1964) Tyrosine hydroxylase: The initial step in norepinephrine biosynthesis. J Biol Chem 239:2910-2917.
46. Narhi L, Wood SJ, Steavenson S, Jiang Y, Wu GM, Anafi D, Kaufman SA, Martin F, Sitney K, Denis P, Louis JC, Wypych J, Biere AL, Citron M (1999) Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation. J Biol Chem 274:9843-9846.
47. Neystat M, Lynch T, Przedborski S, Kholodilov N, Rzhetskaya M, Burke R (1999) α-synuclein expression in substantia nigra and cortex in Parkinson's disease. Mov Disord 14:417-422.
48. Nirenberg MJ, Chan J, Liu Y, Edwards RH, Pickel VM (1996) Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: Potential sites for somatodendritic storage and release of dopamine. J Neurosci 16:4135-4145.
49. O'Hara CM, Uhland-Smith A, O'Malley KL, Todd RD (1996) Inhibition of dopamine synthesis by dopamine D2 and D3 but not D4 receptors. J Pharmacol Exp Ther 277:186-192.
50. Ostrerova N, Petrucelli L, Farrer M, Mehta N, Choi P, Hardy J, Wolozin B (1999) α-synuclein shares physical and functional homology with 14-3-3. J Neurosci 19:5782-5791.
51. Payton JE, Perrin RJ, Wraight L, Clayton DF, George JM (2001) Anomalous immunoreactivity of the Syn-1 antibody to α-synuclein. Soc Neurosci Abstr 27:934.
52. Perez RG, Squazzo SL, Koo EH (1996) Enhanced release of amyloid β-protein from codon 670/671 "Swedish" mutant β-amyloid precursor protein occurs in both secretory and endocytic pathways. J Biol Chem 271:9100-9107.
53. Perez RG, Soriano S, Hayes JD, Ostaszewski B, Xia W-M, Selkoe DJ, Chen X, Stokin G, Koo EH (1999) Mutagenesis identifies new signals for β-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Aβ42. J Biol Chem 274:18851-18856.
54. Pickel VM, Joh TH, Reis DJ (1975) Ultrastructural localization of tyrosine hydroxylase in noradrenergic neurons of brain. Proc Natl Acad Sci USA 72:659-663.
55. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276:2045-2047.
56. 3H]-tyrosine by charcoal. Life Sci 39:2185-2189.
57. Souza JM, Giasson BI, Lee VMY, Ischiropoulos H (2000) Chaperonelike activity of synucleins. FEBS Lett 474:116-119.
58. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) α-synuclein in Lewy bodies. Nature 388:839-840.
59. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) α-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 95:6469-6473.
60. Stefanis L, Larsen KE, Rideout HJ, Sulzer D, Greene LA (2001) Expression of A53T mutant but not wild-type α-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J Neurosci 21:9549-9560.
61. Stokes AH, Hastings TG, Vrana KE (1999) Cytotoxic and genotoxic potential of dopamine. J Neurosci Res 55:659-665.
62. Takeda A, Hashimoto M, Mallory M, Sundsumo M, Hansen L, Sisk A, Masliah E (1998) Abnormal distribution of the non-Abeta component of Alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment. Lab Invest 78:1169-1177.
63. Tanji M, Horwitz R, Rosenfeld G, Waymire JC (1994) Activation of protein kinase C by purified bovine brain 14-3-3: Comparison with tyrosine hydroxylase activation. J Neurochem 63:1908-1916.
64. Tokuyasu KT (1989) Use of poly(vinylpyrrolidone) and poly(vinylalcohol)for cryo-ultramicrotomy. Histochem J 21:163-171.
65. Ueda S, Aikawa M, Ishizuya-Oka A, Yamaoka S, Koibuchi N, Yoshimoto K (2000) Age-related dopamine deficiency in the mesostriatal dopamine system of zitter mutant rats: Regional fiber vulnerability in the striatum and the olfactory tubercle. Neuroscience 95:389-398.
66. Van Der Hoeven PC, Van Der Wal JC, Ruurs P, Van Blitterswijk WJ (2000) Protein kinase C activation by acidic proteins including 14-3-3. Biochem J 347:781-785.
67. van der Putten H, Wiederhold KH, Probst A, Barbieri S, Mistl C, Danner S, Kauffmann S, Hofele K, Spooren WP, Ruegg MA, Lin S, Caroni P, Sommer B, Tolnay M, Bilbe G (2000) Neuropathology in mice expressing human alpha-synuclein. J Neurosci 20:6021-6029.
68. Wagner J, Palfreyman M, Zraika M (1979) Determination of dopa, dopamine, dopac, epinephrine, norepinephrine, alpha-monofluoromethyldopa and alpha-difluoromethyldopa in various tissues of mice and rats using reversed-phase ion-pair liquid chromatography with electrochemical detection. J Chromatogr 164:41-54.
69. Waymire JC, Johnston JP, Hummer-Lickteig K, Lloyd A, Vigny A, Craviso GL (1988) Phosphorylation of bovine adrenal chromaffin cell tyrosine hydroxylase. Temporal correlation of acetylcholine's effect on site phosphorylation, enzyme activation, and catecholamine synthesis. J Biol Chem 263:12439-12447.
70. Waymire JC, Craviso GL, Lichteig K, Johnston JP, Baldwin C, Zigmond RE (1991) Vasoactive intestinal peptide stimulates catecholamine biosynthesis in isolated adrenal chromaffin cells: Evidence for a cyclic AMP-dependent phosphorylation and activation of tyrosine hydroxylase. J Neurochem 57:1313-1324.
71. Withers GS, George JM, Banker GA, Clayton DF (1997) Delayed localization of synelfin (synuclein, NACP) to presynaptic terminals in cultured rat hippocampal neurons. Brain Res Dev Brain Res 99:87-94.
72. Zhang L, Wang H, Liu D, Liddington R, Fu H (1997) Raf-1 kinase and exoenzyme S interact with 14-3-3 zeta through a common site involving lysine 49. J Biol Chem 272:13717-13724.
73. Zhou W, Hurlbert MS, Schaack J, Prasad KN, Freed CR (2000) Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells. Brain Res 866:33-43.